Business Model

Ravian specializes in developing new formulations, undertaking bioequivalence studies, and clinical trials, obtaining the Drug Controller General of India’s (DCGI) approval for manufacturing and marketing of new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Ravian’s technology to its customers under their brand names. Ravian manufactures innovative and technology-driven products